Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide 1”

672 trials

Showing 20 of 672 results

Early research (Phase 1)Study completedNCT00745186
What this trial is testing

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

Who this might be right for
Hypoglycemia
Hospira, now a wholly owned subsidiary of Pfizer 28
Testing effectiveness (Phase 2)Study completedNCT05500586
What this trial is testing

The Effects of Glucagon on Hepatic Metabolism

Who this might be right for
ObesityType2diabetesNAFLD
Adrian Vella 21
Testing effectiveness (Phase 2)Study completedNCT01556594
What this trial is testing

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia

Who this might be right for
Hypoglycemia
Eli Lilly and Company 18
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Large-scale testing (Phase 3)Study completedNCT05680129
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 623
Not applicableStudy completedNCT03526445
What this trial is testing

Hepatic Metabolic Changes in Response to Glucagon Infusion

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseTotal PancreatectomyDiabetes Mellitus
Steno Diabetes Center Copenhagen 27
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Early research (Phase 1)Study completedNCT03965130
What this trial is testing

The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA

Who this might be right for
Healthy Participants
Yale University 10
Not applicableStudy completedNCT01021865
What this trial is testing

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus Type 2
Mayo Clinic 33
Not applicableNot Yet RecruitingNCT07701460
What this trial is testing

Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1

Who this might be right for
Weight Maintenance
Tufts University 200
Large-scale testing (Phase 3)Study completedNCT04039503
What this trial is testing

Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 475
Not applicableStudy completedNCT04337268
What this trial is testing

Acute Effects of GLP-1 on Renal Hemodynamics

Who this might be right for
The GLP-1-mediated Gut-kidney Axis
Rigshospitalet, Denmark 10
Early research (Phase 1)Study completedNCT02163278
What this trial is testing

A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
National Health Research Institutes, Taiwan 32
Not applicableStudy completedNCT02879955
What this trial is testing

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Who this might be right for
Overweight
Hvidovre University Hospital 20
Post-approval studies (Phase 4)UnknownNCT00155376
What this trial is testing

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Who this might be right for
Liver Disease
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT01900340
What this trial is testing

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

Who this might be right for
Appetite and General Nutritional Disorders
University Hospital, Basel, Switzerland 12
Early research (Phase 1)Study completedNCT01373450
What this trial is testing

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Large-scale testing (Phase 3)Study completedNCT02171130
What this trial is testing

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

Who this might be right for
HypoglycemiaDiabetes MellitusDrug-Specific Antibodies
Eli Lilly and Company 129
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation